SARS_CoV 2 Clinical Trials in Baltimore

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) - 2022
Completed
  • SARS-CoV 2
  • Los Angeles, California
  • +10 more
2022-03-17
Mar 17, 2022
J
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
Active, not recruiting
  • SARS-CoV 2
  • SARS-CoV-2 convalescent plasma
  • Plasma from a volunteer donor
  • Birmingham, Alabama
  • +24 more
2021-11-15
Nov 15, 2021
S
Trial to Promote Recovery From COVID-19 With Endocrine Therapy
Withdrawn
  • COVID-19
  • SARS-CoV 2
  • Bicalutamide 150 Mg Oral Tablet
  • Baltimore, Maryland
    Johns Hopkins Hospital
2021-03-02
Mar 2, 2021